SBI Securities Co. Ltd. Invests $41,000 in DaVita Inc. (NYSE:DVA)

SBI Securities Co. Ltd. acquired a new position in shares of DaVita Inc. (NYSE:DVA) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 271 shares of the company’s stock, valued at approximately $41,000.

Other institutional investors also recently modified their holdings of the company. Quarry LP acquired a new position in shares of DaVita during the 3rd quarter worth about $60,000. Venturi Wealth Management LLC grew its stake in DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after buying an additional 152 shares during the last quarter. Versant Capital Management Inc grew its stake in DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after buying an additional 169 shares during the last quarter. Blue Trust Inc. grew its stake in DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after buying an additional 131 shares during the last quarter. Finally, Jones Financial Companies Lllp grew its stake in DaVita by 28.6% in the 4th quarter. Jones Financial Companies Lllp now owns 517 shares of the company’s stock valued at $77,000 after buying an additional 115 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Barclays increased their target price on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a research note on Friday, February 21st. Finally, Cowen reaffirmed a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $166.33.

DaVita Stock Down 3.4 %

DVA opened at $146.71 on Wednesday. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The company’s 50-day moving average is $159.41 and its 200 day moving average is $157.90. DaVita Inc. has a fifty-two week low of $125.64 and a fifty-two week high of $179.60. The firm has a market capitalization of $11.74 billion, a P/E ratio of 13.66, a PEG ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.